Lineages and sublineages of human papillomavirus type 16 in cervical samples of Iranian women-Reference-Cited by-同舟云学术

Lineages and sublineages of human papillomavirus type 16 in cervical samples of Iranian women

Published:2023-03 Issue:4 Volume:18 Page:215-224
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Salehi-Vaziri Mostafa¹²^ORCID,Sadeghi Farzin²³,Haeri Hayedeh⁴,Bokharaei-Salim Farah⁵,Monavari Seyed Hamidreza⁵,Hashemi Firoozeh Sadat⁶,Jalilvand Somayeh²^ORCID,Keyvani Hossein⁵

Affiliation:

1. Department of Arboviruses and Viral Hemorrhagic Fever, Pasteur Institute of Iran, Tehran, Iran

2. Department of Virology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

3. Department of Immunology & Microbiology, School of Medicine, Babol University of Medical Sciences, Babol, Iran

4. Department of Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

5. Department of Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

6. Department of Gynecology Oncology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Aim: This study was designed to analyze intratypic variations of human papillomavirus type 16 (HPV16) and to assess the risk of these variants for progression to cervical cancer. Materials & Methods: HPV16 variants of 58 women were determined by PCR-directed sequencing. Results: The most frequent lineage was D (67.2%) followed by A (32.8%). Lineage A was found predominantly in normal (62.5%) and cervical intraepithelial neoplasia-1 (CIN-1) (83.3%), while lineage D was the most prevalent variant in cervical cancer (100%). Conclusion: The present study revealed a distinct pattern of HPV16 variants in Iran. Based on our data, the predominant HPV16 lineage was D and there was a significant association between lineage D variants and cervical cancer.

Funder

Tehran University of Medical Sciences and Health Services

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2022-0174

Reference49 articles.

1. GLOBOCAN. Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2020 (2020).

2. Human papillomavirus (HPV) 18 genetic variants and cervical cancer risk in Taizhou area, China

3. Cervical cancer

4. Genotype distribution of Human Papillomavirus (HPV) in patients with Recurrent Respiratory Papillomatosis (RRP) in Iran